Read + Share
Grossman SA. Using Historical Objective Response Rates to Design Single Arm Phase II Trials in
Patients with Recurrent Glioblastoma. Neuro Oncol 2023 Mar 7:noad046. doi: 10.1093.
PMID: 36881776
|
 |
|
Grossman SA. Using Historical Objective Response Rates to Design Single Arm Phase II Trials in
Patients with Recurrent Glioblastoma. Neuro Oncol 2023 Mar 7:noad046. doi: 10.1093.
PMID: 36881776
|
|
|
|